IDH3A and metabolic dysfunction-associated steatohepatitis: In addition, isocitrate dehydrogenase (IDH) is a key rate-limiting enzyme in the TCA cycle, which seems to be in line with the changes in hepatic IDH gene expression and the increase in plasma isocitrate in patients with NASH in the present study.